Entry conditions:
(i) lower share price for
EMR along with swing of DMI indicator towards bearishness and RSI downwards, and
(ii) observing market reaction around the share price of $6.34 (prior support from 06-Feb).
Depending on risk tolerance, the stop loss for the trade would be:
(i) above the declining yearly VWAP on the daily chart (currently $6.94), or
(ii) above the recent potential resistance level from the open of 21st January ($7.22).
(i) lower share price for
(ii) observing market reaction around the share price of $6.34 (prior support from 06-Feb).
Depending on risk tolerance, the stop loss for the trade would be:
(i) above the declining yearly VWAP on the daily chart (currently $6.94), or
(ii) above the recent potential resistance level from the open of 21st January ($7.22).
Order cancelled
UPDATE (week ending 20-Feb): Poor bearish market reaction observed on Wednesday regarding the prior support from 06-Feb (i.e.: $6.34 level), with no strength in the bearish move as per prescribed entry conditions. Therefore, trade abandoned - let's look for other opportunities.Join the socials here:
ivorywolf.start.page/ (Facebook / Telegram / YouTube)
Like/join/subscribe for the latest stock/crypto coverage!
...
ivorywolf.start.page/ (Facebook / Telegram / YouTube)
Like/join/subscribe for the latest stock/crypto coverage!
...
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Join the socials here:
ivorywolf.start.page/ (Facebook / Telegram / YouTube)
Like/join/subscribe for the latest stock/crypto coverage!
...
ivorywolf.start.page/ (Facebook / Telegram / YouTube)
Like/join/subscribe for the latest stock/crypto coverage!
...
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
